Advanced search
Publication Cover
Scandinavian Journal of Infectious Diseases Volume 36, 2004 - Issue 6-7
Submit an article Journal homepage
39
Views
22
CrossRef citations to date
0
Altmetric
CASE REPORT

Treatment of Vancomycin-intermediate Staphylcoccus aureus Endocarditis with Linezolid

K.T. Leung From the Department of Medicine and Department of Microbiology, Tuen Mun Hospital, Tuen Mun, Hong Kong
,
M.K.H. Tong From the Department of Medicine and Department of Microbiology, Tuen Mun Hospital, Tuen Mun, Hong KongCorrespondence[email protected]
,
Y.P. Siu From the Department of Medicine and Department of Microbiology, Tuen Mun Hospital, Tuen Mun, Hong Kong
,
C.S. Lam From the Department of Medicine and Department of Microbiology, Tuen Mun Hospital, Tuen Mun, Hong Kong
,
H.L. Ng From the Department of Medicine and Department of Microbiology, Tuen Mun Hospital, Tuen Mun, Hong Kong
&
H.K. Lee From the Department of Medicine and Department of Microbiology, Tuen Mun Hospital, Tuen Mun, Hong Kong
Pages 483-486 | Received 22 Apr 2004, Accepted 11 May 2004, Published online: 08 Jul 2009

References

  • Jevons MP Celbenin-resistant staphylococci. Br Med J 1961; 1: 124–6.
  • Hiramatsu K, Hanaki H, Ino T. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135–6.
  • Andrade-Baiocchi S, Tognim MC, Baiocchi OS, Sader HS. Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization. Diagn Microbiol Infect Dis 2003; 45: 149–52.
  • Smith TL, Pearson NL, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Eng J Med 1999; 340: 493–501.
  • Howden BP, Ward PB, Charles PG, Korman TM, Fuller A, du Cros P, et al. Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility. Clin Infect Dis 2004; 38: 521–8.
  • Sieradzki K, Roberts RB, Haber SA, Tomaz A. The development of vancomycin resistance in a patient with methicillin-resistant Staplylococcus aureus infection. N Eng J Med 1999; 340: 517–23.
  • Green SL, Maddox JC, Huttenbach ED. Linezolid and reversible myelosuppression [Letter]. JAMA 2001; 285: 1291.
  • Vouillamoz J, Entenza JM, Feger C, Glauser MP, Moreillon P Quinupristin-dalfopristin combined with β–lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics. Antimicrob Agents Chemother 2000; 44: 1789–95.
  • Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001; 358: 207–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.